G U1.52.15
A medical device company has developed a new needle that they claim reduces the incidence of injection-site
reactions for a particular medication. An experiment is to be conducted to determine if there is sufficient evidence to
make that claim.
Which of the following is a correct description and consequence of a Type II error?
O A Type Il error would occur if the medical device company incorrectly administers the medication with the new
needle, causing it to be impossible to determine whether the number of injection-site reactions have increased or
decres ith the new needle.
O A Type Il error would occur if, in reality, the new needle does not reduce the incidence of injection-site reactions, but
the significance test detects such a difference. The consequence of such an error would be that the medical device
company would produce this new needle, but it would not be beneficial.
O A Type Il error would occur if, in reality, the new needle reduces the incidence of injection-site reactions, but the
significance test does not detect this difference. The consequence of such an error would be that the medical device
company would produce this new needle, but it would not be beneficial
O A Type II error would occur if, in reality, the new needle does not reduce the incidence of injection-site reactions, but
the significance test detects such a difference. The consequence of such an error would be that the medical device
company would not produce this new needle when it could have been beneficial.
Save and Exit
Next
Submit
Mark this and return